Latest Research Reports

Monoclonal antibodies make up seven out of the top ten investigated drugs in 2016

Monoclonal antibodies make up seven out of the top ten investigated drugs in 2016

Novartis, Pfizer, Amgen, and Merck: key players in the autoimmune biosimilars space

Novartis, Pfizer, Amgen, and Merck: key players in the autoimmune biosimilars space

EMA set to approve plethora of oncology drugs

EMA set to approve plethora of oncology drugs

Top indications and therapy areas for 2012-2016 clinical trials in Israel

Top indications and therapy areas for 2012-2016 clinical trials in Israel

Orphan cancer drugs take up 37% of market share

Orphan cancer drugs take up 37% of market share

US and UK stand out with higher disease prevalence of two autoimmune diseases

US and UK stand out with higher disease prevalence of two autoimmune diseases

Is diagnosed non-invasive ductal carcinoma in-situ breast cancer rarer in China?

Is diagnosed non-invasive ductal carcinoma in-situ breast cancer rarer in China?

Anticipated approval timeline of PARP inhibitors in HER2-negative breast cancer

Anticipated approval timeline of PARP inhibitors in HER2-negative breast cancer

A look at atrial fibrillation’s market size forecast

A look at atrial fibrillation’s market size forecast

Industry-sponsored clinical trials initiated in Q1 2017

Industry-sponsored clinical trials initiated in Q1 2017

China shows leading emerging market growth in R&D spend

While the global pharmaceutical markets have typically been dominated by US, Europe and Japan, emerging markets have been steadily increasing their prominence in the global space over the...

China shows leading emerging market growth in R&D spend

Innovative new drugs could produce a watershed moment for dermatology sufferers

Innovative new drugs could produce a watershed moment for dermatology sufferers

Pharma licensing deals 2016/2017 comparison

Pharma licensing deals 2016/2017 comparison

Brazil: 2016 clinical trials activity at lowest point in five years

Brazil: 2016 clinical trials activity at lowest point in five years

Eylea enables Regeneron to dominate the ocular market

Eylea enables Regeneron to dominate the ocular market

Top oncology revenue generators: what will the next five years bring?

Top oncology revenue generators: what will the next five years bring?

A serious threat on the horizon for Imbruvica

A serious threat on the horizon for Imbruvica

UK and Australian health authorities disagree over E-cigarettes

UK and Australian health authorities disagree over E-cigarettes

Can tanezumab provide safer and more effective treatment for cancer pain management?

More than half of all cancer patients experience pain as a result of their cancer, current treatment options are lacking and can leave patients suffering with chronic pain, which can...

Can tanezumab provide safer and more effective treatment for cancer pain management?

Can vaccines treat colorectal cancer effectively with no side effects?

Colorectal cancer (CRC) is the third most common type of cancer in the US, and its treatment is often associated with severe side...

Can vaccines treat colorectal cancer effectively with no side effects?

Report: Novel pipeline products to drive schizophrenia market growth

Report: Novel pipeline products to drive schizophrenia market growth